GPLL completes merger with Global Pharma Labs; Labs becomes subsidiary

GPL Holdings, Inc.

Merger effective August 14, 2023; Labs survives as wholly owned subsidiary of GPLL.
Each Labs share converted into right to receive equivalent GPLL common stock.
Merger intended to be tax-free reorganization for U.S. federal income tax purposes.
Stockholder consent obtained; notice mailed to Labs stockholders on August 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GPL Holdings, Inc. entered into Agreement and Plan of Merger with Global Pharma Labs, Inc. and GPL Merger Sub, Inc. (effective 2023-08-07).

Action: entry
Agreement: merger
Counterparty: Global Pharma Labs, Inc. and GPL Merger Sub, Inc.
Effective: 2023-08-07

Exact text from the filing

On August 7, 2023, GPL Holdings, Inc., a Nevada corporation (“GPLL”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Global Pharma Labs, Inc., a Delaware corporation (“Labs”), and GPL Merger Sub, Inc., (“Merger Sub”) a Delaware corporation and a wholly owned subsidiary of GPLL.

View on SEC.gov

Browse all material agreements →

GPL Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001883083-23-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.